Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Neola Medical

0.66 SEK+26.92 %7.9, 12.57
Less than 1K followers

NEOLA

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor views
Compare
+26.92 %
+10.92 %
-33.33 %
-22.35 %
-35.54 %
-70.67 %
-51.71 %
-78.29 %
-87.69 %

Neola Medical operates in the medical technology sector. The company focuses on neonatal care, where it develops medical equipment. Examples of products that the company provides to the healthcare sector include technical monitoring and follow-up of lung capacity in premature infants. In addition to the main product, ancillary products and disposables are offered. The largest operations are found in the Nordic market. Neola Medical was founded in 2016 and is headquartered in Sweden.

Read more
Market cap
72.91M SEK
Turnover
705.82K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
18.11
2026

Interim report Q3'26

All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue K

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release04.09.2026, 19.38

Neola Medical Receives FDA Breakthrough Device Designation

Neola Medical
Press release31.08.2026, 07.30

Neola Medical Granted U.S. Design Patent Strengthening Protection of Neola® User Interface

Neola Medical
Press release24.08.2026, 11.23

Redeye: Neola Medical (Q2 Review): Funding secured, focus shifts to 2027 studies

Neola Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release20.08.2026, 07.00

Neola Medical Q2 Report 2026 – Clinical progress, secured financing and sharpened focus

Neola Medical
Press release12.08.2026, 07.30

Neola Medical invites to presentation of the Q2 report 2026

Neola Medical
Press release10.06.2026, 07.30

Neola Medical granted Patent in the U.S. for reducing optical noise in lung monitoring measurements

Neola Medical
Press release03.06.2026, 07.30

Neola Medical to Present at Aktiedagarna: Advancing U.S. Market Preparations Following Positive Clinical Safety Results

Neola Medical
Press release20.05.2026, 11.20

Redeye: Neola Medical (Q1 Review): An undramatic report after an eventful period

Neola Medical
Regulatory press release19.05.2026, 07.00

Neola Medical Q1 Report 2026 – Positive safety results from clinical study in preterm born babies strengthen the path toward market

Neola Medical
Regulatory press release21.04.2026, 07.00

Neola Medical Reports Positive Safety Results from First Clinical Pilot Study and Advances Towards Next Phase of Clinical Development

Neola Medical
Press release16.03.2026, 07.05

Neola Medical Completes Enrollment in Swedish Clinical Pilot Study

Neola Medical
Press release13.02.2026, 12.59

Redeye: Neola Medical (Q4 Review): Eyes on upcoming clinical data

Neola Medical
Regulatory press release12.02.2026, 07.00

Neola Medical Q4 Report 2025 – Advancing IP Protection as a Core Strategic Asset across Key Markets

Neola Medical
Press release05.02.2026, 08.00

Neola Medical invites to presentation of the Q4-report 2025

Neola Medical
Press release17.12.2025, 11.40

Neola Medical’s CEO shares recent company highlights in winter 2025 investor letter

Neola Medical
Regulatory press release09.12.2025, 07.00

Neola Medical expands leadership team with appointment of Director Disposable Product Development

Neola Medical
Press release02.12.2025, 07.00

Neola Medical granted U.S. patent for disposable probes, strengthening future revenue model in target market

Neola Medical
Press release13.11.2025, 07.00

Neola Medical granted Patent in China for reducing optical noise in lung monitoring measurements

Neola Medical
Press release07.11.2025, 08.37

Redeye: Neola Medical (Q3 Review) - Revised timeline

Neola Medical
Regulatory press release04.11.2025, 18.57

Neola Medical Q3 Report 2025 – Progressing toward completion of Swedish clinical pilot study and strengthening leadership team

Neola Medical